Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.00

+0.50 (0.93%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

1635 watching

Investor Insights

Jun 6, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by many experts, who highlight its strong performance in Asia and robust wealth management services. The company is seen as a good long-term investment, particularly due to its attractive dividend yield and relatively low price-to-earnings ratio compared to banks. However, there are concerns regarding short-term earnings fluctuations, particularly in alternative portfolio results and U.S. operations. Market analysts suggest that while the stock has had a good run, cautious investors should watch for strategic entry points, as some believe it may be susceptible to macroeconomic challenges. Overall, the sentiment is that MFC is a solid income stock with potential for growth as it continues to navigate its complex business landscape.

Consensus

Hold

Valuation

Fair Value

Similar

GWO

TOP PICK

4.079% Aug 20, 2014 bonds. 3.5% yield currently. Senior debt. Short compared to others.

Wealthica Track your Stocks in your Watch List

DON'T BUY

Life insurance companies are supposed to be defensive but this one missed the boat entirely. They then took the hedges off at the bottom of the market. Not going to go down anywhere, it’s just kind of dead.

BUY

Last correction was a higher low so he thinks it goes up. In a nice congestive period currently.

HOLD

Struggled over last couple of years but are getting act together recently. With hedging program in place they are little less prone to ups and down in the market. Bought more recently. Good valuation. Nothing is going happen here soon. In 3-5 years they will turn things around. Growth is in China.

TOP PICK

Pretty much carrying out the plan that Don Guloien laid out for them a couple of years ago. Have de-risked. Last quarter was good. Over time they will get back to the 12%-14% ROE.

PAST TOP PICK

Manulife down since May 28 2010(recommended at $17.58 now at $17.16, Total return 0.91% increase), earnings were solid until last quarter, this is a work through story which will probably take a year or two to play itself out.He thinks it will be worth more but not sure when.

BUY

Market gave it a very high multiple when it was doing crazy things and now everyone hates it when it is doing all the right things. Very cheap multiple and are solving a lot of their issues. Have some really great growth aspects, not only in the US but also in Asia where they are dedicating more capital.

BUY

Just reported and beat their earnings by a large margin. Should continue to do well.

Wealthica Track your Stocks in your Watch List

TOP PICK

They have probably passed the bottom. They are now about a third Asia, which is growing quite quickly. They are at the end of 2012 target and balance sheet is way above what is regulated. Have enough capital to raise dividend but they will wait.

BUY

Very good way of playing both the stock market and interest rates. One of the few ways to make money if interest rates rise. Also a positive leverage to the stock market with their variable annuities.

BUY

Is a long-term sufferer on this name. He likes to buy sticks when people hate the names. People don’t understand what’s going on with MFC. Earnings could reach $2-$2.50 normalized in 2-3 years. Trading near book value. Actively putting new clients into it.

BUY

Thinks it’s time to get back in. They’re getting their act together again. Looking attractive. Great international exposure. Thinks it could be earning $2.50-$3 a share in 2 to 3 years without a lot of problem. With a 12 multiple, you are looking at a $30 plus stock along with a dividend.

COMMENT

On his watch list. Two major factors will impact this stock. As interest rates go up, the company will do much better as it will help their bottom line. Market movement t will also affect them. Too expensive for him at this point.

TOP PICK

Over the last couple of years they made significant strides in hedging out a lot of their risk. We are now in a much better environment for insurance companies.

SELL

Significant dividend but this is a company that has a cloud over it again. When clients bring it in from outside, he tends to eliminate it. He not sure about their equity oriented investment insurance type plans. On a market, which he expects will be indifferent over the next 3 or 4 months, this stock won’t do very well. Their most recent earnings report was a disappointment. Also the Japan situation might come back and bite them.

Showing 1,306 to 1,320 of 2,279 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)